Important Safety Information
Compounded enclomiphene citrate (off-label)
Enclomiphene citrate is a selective estrogen receptor modulator (SERM) prescribed off-label by licensed providers to support endogenous testosterone production in men with secondary hypogonadism. Enclomiphene citrate is not currently FDA-approved as a standalone product and is dispensed as a compounded preparation through a state-licensed compounding pharmacy.
Enclomiphene/clomiphene-class medications may cause:
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. You may also report side effects to the manufacturer or to your NowYou care team.
This summary does not include all information about this medication. It is not a substitute for the full Prescribing Information or for talking with your healthcare provider. Please read the full Prescribing Information and Medication Guide before starting treatment, and discuss any questions with your provider.
This safety summary is provided for educational purposes and does not replace the full Prescribing Information, Medication Guide, or professional medical advice. Always discuss benefits, risks, and alternatives with your licensed provider.